Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7064281 | 0.90 | HSD11B1 (0.31) | HSD11B1 | |
| SCHEMBL706994 | 0.75 | CHRNB2 (0.39) | EPHX2 | |
| SCHEMBL15840889 | 0.70 | HSD11B1 (0.42) | HSD11B1EPHX2TSHR | |
| SCHEMBL8781862 | 0.69 | EPHX2 (0.36) | HSD11B1EPHX2 | |
| SCHEMBL76842 | 0.65 | CYP2C9 (0.41) | — | |
| SCHEMBL2707599 | 0.64 | CYP2C9 (0.32) | — | |
| SCHEMBL7978669 | 0.64 | GRM5 (0.34) | HSD11B1TSHR | |
| SCHEMBL5408967 | 0.63 | POLB (0.35) | TSHR | |
| SCHEMBL7794306 | 0.62 | GAA (0.32) | — | |
| SCHEMBL16698251 | 0.62 | HSD11B1 (0.48) | HSD11B1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112239623-B | Polymer for display device | 罗门哈斯电子材料有限责任公司 | 2022-10-04 | — | — | CN | claimed |
| CN-112239623-A | Polymer for display device | 罗门哈斯电子材料有限责任公司 | 2021-01-19 | — | — | CN | claimed |
| EP-2633099-B1 | AQUEOUS COMPOSITION FOR PRETREATING A METAL SURFACE BEFORE APPLYING ANOTHER COATING OR FOR TREATING SAID SURFACE | CHEMETALL GMBH (DE) | 2019-07-03 | — | — | EP | claimed |
| US-9481935-B2 | Aqueous composition for pretreating a metal surface before applying another coating or for treating said surface | CHEMETALL GMBH (DE) | 2016-11-01 | — | — | US | claimed |
| EP-2280970-B1 | IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS | HOFFMANN LA ROCHE (CH) | 2014-01-08 | — | — | EP | claimed |
| US-20130295292-A1 | AQUEOUS COMPOSITION FOR PRETREATING A METAL SURFACE BEFORE APPLYING ANOTHER COATING OR FOR TREATING SAID SURFACE | CHEMETALL GMBH (DE) | 2013-11-07 | — | — | US | claimed |
| US-8182865-B2 | Process for producing a repair coating on a coated metallic surface | CHEMETALL GMBH (DE) | 2012-05-22 | — | — | US | claimed |
| US-8124636-B2 | Imidazolidinone derivatives as 11B-HSD1 inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2012-02-28 | — | — | US | claimed |
| EP-2280970-A1 | IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2011-02-09 | — | — | EP | claimed |
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2010-12-16 | — | — | US | claimed |
| WO-2009132986-A1 | IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-11-05 | — | — | WO | claimed |
| US-20090275573-A1 | Imidazolidinone Derivatives as 11B-HSD1 Inhibitors | HOFFMANN-LA ROCHE, INC. | 2009-11-05 | — | — | US | claimed |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | claimed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | claimed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| EP-1004568-B1 | Novel ester compounds, polymers, resist compositions and patterning process | SHINETSU CHEMICAL CO (JP) | 2006-01-25 | — | — | EP | claimed |
| US-6596463-B2 | Photosensitivity, resolution, chemical resistance | SHIN-ETSU CHEMICAL, CO., LTD. (JP) | 2003-07-22 | — | — | US | claimed |
| US-6312867-B1 | Ester compounds, polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-11-06 | — | — | US | claimed |
| CN-118240154-A | Curable composition and film made therefrom | 罗门哈斯电子材料韩国有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-0820444-A1 | 1-PHENYLPYRAZOLE-3-CARBOXAMIDES ACTING ON NEUROTENSIN RECEPTORS | SANOFI (FR) | 1998-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317653-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | DGAT1, DGAT2, GPR119 | HSD11B1 117/4885EPHX2 2036/4885TSHR 1451/4885 |
| US-20090275573-A1 | Imidazolidinone Derivatives as 11B-HSD1 Inhibitors | HSD11B1, HSD17B1, HSD17B11 | HSD11B1 1/4885EPHX2 2366/4885TSHR 1734/4885 |
| US-20080096874-A1 | Oxadiazole Derivative as Dgat Inhibitors | DGAT1, DGAT2, GPR119 | HSD11B1 126/4885EPHX2 2517/4885TSHR 1169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.